Last reviewed · How we verify

NCT04861272

Risk Perception Associated With Covid-19 Among Anesthetists

Status unknown Last updated 27 April 2021
What this trial tests

trial testing Survey in Cross Sectional Hospital Based Study in 1,000 participants. Status unknown.

Timeline
15 April 2021
Primary endpoint
5 May 2021
15 May 2021

Quick facts

Lead sponsorKing Saud University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment1,000
Start date15 April 2021
Primary completion5 May 2021
Estimated completion15 May 2021
Sites1 location across Saudi Arabia

Drugs / interventions tested

Conditions studied

Sponsor

King Saud University

Who can join

Adults 18 to 65, any sex, with Cross Sectional Hospital Based Study. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Since the outbreak of the COVID-19 pandemic, the anesthesiologists are involved in the riskiest interventions e.g. airway management, endotracheal intubation, and resuscitation. So, they are subjected to a higher risk of infection compared to many other medical specialties. As a result, they are more subjected to psychological stresses. This study aimed to assess the level of stress associated with the COVID-19 pandemic among anesthesiologists.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Survey

Trials testing the same drug.

Other King Saud University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04861272.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing